MedTrace Logo

Cytomegalovirus Reactivation in Cancer Patients Receiving Chemotherapy

NCT00366717 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2006-08-21

No results posted yet for this study

Summary

Cytomegalovirus (CMV) infects most of the world population. This study is to understand if chemotherapy will increase the chance of reactivating CMV. The results may help us in determining when treatment is needed and perhaps Why is it needed.

Conditions

Sponsors & Collaborators

  • Mackay Memorial Hospital

    lead OTHER

Principal Investigators

  • Yen-Ta Lu, MD, PhD. · Mackay Memorial Hospital

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2006-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00366717 on ClinicalTrials.gov